Erdogan-Trinkaus Ipek

Erdogan-Trinkaus Ipek is listed in filings as Chief Commercial Officer at Eton Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 14, 2026, including 3 public disclosures. Recent filings connect the profile to Eton Pharmaceuticals, Inc. (ETON). The current snapshot covers public activity from Dec 12, 2025 to Jan 14, 2026. Reported amounts are shown as $1.4K to $628.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.